KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Treasury Shares (2016 - 2026)

Zimmer Biomet Holdings has reported Treasury Shares over the past 18 years, most recently at $9.1 billion for Q1 2026.

  • For Q1 2026, Treasury Shares rose 5.84% year-over-year to $9.1 billion; the TTM value through Mar 2026 reached $9.1 billion, up 5.84%, while the annual FY2025 figure was $8.9 billion, 5.75% up from the prior year.
  • Treasury Shares for Q1 2026 was $125.9 million at Zimmer Biomet Holdings, up from $123.2 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $125.9 million in Q1 2026 and troughed at -$120.5 million in Q1 2025.
  • A 5-year average of -$29.2 million and a median of -$104.8 million in 2022 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: dropped 0.01% in 2022 and later grew 17.2% in 2024.
  • Year by year, Treasury Shares stood at $6.9 billion in 2022, then rose by 10.12% to $7.6 billion in 2023, then rose by 11.15% to $8.4 billion in 2024, then grew by 5.75% to $8.9 billion in 2025, then grew by 2.83% to $9.1 billion in 2026.
  • Business Quant data shows Treasury Shares for ZBH at $9.1 billion in Q1 2026, $8.9 billion in Q4 2025, and $8.6 billion in Q3 2025.